Showing posts with label Orbisresearch Pharmaceuticals Market Research Report. Show all posts
Showing posts with label Orbisresearch Pharmaceuticals Market Research Report. Show all posts

Monday, 4 December 2017

Biomaterials Market : Trends & Opportunities (2017-2022) - New Report by Orbis Research


Latest Report Available at Orbis research Biomaterials Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/219788  .

The Global market for Biomaterials has been estimated to be USD 54.65 billion in 2014 and it is projected to reach USD 115 billion by the end of 2020 at a CAGR of 13.2% during the forecast period from 2014 to 2021. Biomaterial is a biological or synthetic substance used to make devices to replace a part or an organ in a safe, reliable & compatible to the body. Biomaterials can be either extracted from the nature or synthesized using artificial processes. The usage of biomaterials is based on factors like its biocompatibility, bio-functionality & availability.

Biomaterials are used in plastic surgery, joint replacements, drug delivery devices, heart valves and in other medical implants. The medicinal areas which use biomaterials include Cardiovascular Medicine, Orthopedics, Dental Medicine, Ophthalmology, immunology, infection and others. The launch of new products in areas such as plastic surgery, neurology and wound healing is expected to fuel the growth of this market. The cardiovascular medicine field dominates the global biomaterials market in terms of share due to high prevalence rates of cardiovascular diseases. The orthopedic segment is the second largest market.

Technological advancements, rise in the number of aging people, Increased funds & grants by government bodies worldwide, growing implantable devices market, , rising number of hip and knee replacement procedures, growing incidence of chronic diseases are driving the growth of this market. However, stringent safety and validation regulations, compatibility issues, and difficulty in wearing the products are some of the reasons hindering the growth of the biomaterials market.

The global market for medical biomaterials is segmented based on the Materials and Types. The material segment of the biomaterials market includes metallic, ceramic, polymers, and natural biomaterials. The type segment is sub-divided into Bio-inert Biomaterials, Bioactive Biomaterials & Bio-resorbable Biomaterials. Polymers sub-segment is expected to exhibit fastest growth in the coming years owing to its increased applications in healthcare.

Purchase a copy of Biomaterials Market visit @     http://www.orbisresearch.com/contact/purchase/219788    For more information contact sales@orbisresearch.com       .

Based on geography, the market is segmented into North America, Europe, Asia Pacific and Rest of the World). North America is the largest market for biomaterials owing to the sophisticated healthcare infrastructure and amicable reimbursement policies in this region, followed by Europe. Biomaterials market is expected to witness the highest growth rate in the Asia-Pacific region. Emerging countries such as India and China are contributing for a greater financials in Asia-Pacific biomaterials market because of rising patient awareness coupled with rising healthcare expenditure.

Many players in this market are trying to expand their product portfolio in order to top the global market. While few companies are entering into the market by acquisitions, top companies are expanding their growth in this market by acquiring other companies. The key market players are Royal DSM, Wright Medical Technology, Inc., Corbion N.V., Zimmer Biomet Holdings, Inc., Bayer AG, Carpenter Technology Corporation, Covalon Technologies Ltd., BASF SE, Invibio Ltd., Berkeley Advanced Biomaterials, Inc., and Collagen Matrix, Inc. among others.

Key Deliverables in the Study
Market analysis for the Global Biomaterials Market, with region specific assessments and competition analysis on global and regional scales

Market definition along with the identification of key drivers and restraints
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global Biomaterials Market on both global and regional scales

A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped

Browse Complete Report @  http://www.orbisresearch.com/reports/index/global-biomaterials-market-growth-trends-and-forecasts-2017-2022 .

Some points from TOC:

  1. Introduction
    1.1 Report Description
    1.2 Markets Covered
    1.3 Research Methodology
  2. Executive Summary
  3. Market Overview
    3.1 Market Definition
    3.2 Market Drivers
    3.2.1 Increase in the number of inventions in the field of biomaterials
    3.2.2 Rise in the number of aging people
    3.2.3 Change in the lifestyle
    3.2.4 Rise in the per capita income
    3.3 Market Restraints
    3.3.1 Stringent safety and validation regulations
    3.3.2 Compatibility issues
    3.3.3 Difficulty in wearing the products
    3.4 Market Opportunitites
    3.5 Market Threats
  4. Porters Five Force Analysis
    4.1 Bargaining Power of suppliers
    4.2 Bargaining power of buyers
    4.3 Degree of competition
    4.4 Threat of substitution
    4.5 Threat of new entrants

 For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115

Biopharmaceuticals Market : Trends & Opportunities (2017-2022) - New Report by Orbis Research


Latest Report Available at Orbis research Biopharmaceuticals Market provides pin-point analysis for changing competitive dynamics and a forward looking perspective on different factors driving or restraining industry growth.

Request sample copy of this report @ http://www.orbisresearch.com/contacts/request-sample/219756  .

In the year 2015, the global market for biopharmaceuticals was valued at USD 176.9 billion. It is estimated at USD 192.2 million for the year 2016 and is projected to reach USD 291 billion by the year 2021. The estimated CAGR during the forecast period (2017 - 2022) is 8.6%.

Current trends in biopharmaceuticals market:
On 6th September, Arizona-based company HSRx Biopharmaceutical announced that its orally administered broad-spectrum antiviral drug HSRx 431䋢 is effective against the Zika virus. They plan to test their claim by conducting human trials in 2017, and if these are found to be successful, they plan to seek accelerated drug approval from the U.S. FDA.
With the patents of most of the conventional blockbuster drugs expiring, biopharmaceuticals are currently being considered the next big thing in pharmaceutical industry.
Biopharmaceuticals currently represent a large segment of product pipelines of most of the major pharmaceutical companies.

More than half of the current top 20 blockbuster drugs are biopharmaceuticals.
Monoclonal antibodies currently own the largest market share in terms of value in the global biopharmaceuticals market. Some of the top-selling monoclonal antibodies include Adalimumab, Infliximab, Rituximab and Bevacizumab.
Vaccines represent the second largest segment in biopharmaceuticals market, followed by monoclonal antibodies. Recently, some of the vaccines also achieved blockbuster status with the introduction of vaccines like Gardasil.

Despite the large market size in terms of value, monoclonal antibodies do not lead the biopharmaceuticals market in terms of volume. Vaccines currently represent the largest market segment in the global biopharmaceuticals market in terms of volume.
Biopharmaceuticals currently represent around 20% of the entire pharmaceutical market revenue. This percentage share of biopharmaceuticals in global pharmaceutical market is only expected to increase in the future.

Browse Complete Report @  http://www.orbisresearch.com/reports/index/global-biopharmaceuticals-market-growth-trends-and-forecasts-2017-2022 .

The revenue from sales of biopharmaceuticals represents the major chunk of the total company revenue for several large companies, such as Novartis, AbbVie and Pfizer etc.

Biopharmaceuticals can be considered as one of the most sophisticated and groundbreaking achievements in modern science. Unlike conventional pharmaceuticals that are synthesized by chemical synthesis, biopharmaceuticals are synthesized through biological synthesis in living systems. Due to their biological origin, the biopharmaceuticals show much greater efficacy and efficiency when compared to conventional pharmaceuticals. Since the biopharmaceuticals act by modulation of physiological processes at a cellular level, they can effectively treat the disorders that conventional pharmaceuticals could not treat.

Biopharmaceuticals are the preferred choice of treatment for biomolecule deficiency disorders like hormone deficiency or growth factor deficiency. They can also be used for stimulating and/or suppressing immune reactions, which makes them an ideal treatment option for autoimmune disorders. The most important contribution of biopharmaceuticals is in the field of targeted drug therapy and the use of biopharmaceuticals is revolutionizing this field.

Market Dynamics
Since biopharmaceuticals can technically modulate any physiological pathway that has been fully understood, there is a huge growth potential for the biopharmaceuticals market.

Drivers
As a result of the huge advantages that biopharmaceuticals offer over conventional medicines, their use is continuously increasing. This, combined with the ability of biopharmaceuticals to treat diseases that were previously untreatable, has resulted in a huge market demand, which in turn has increased the profit margins for manufacturers. All these factors together are driving the biopharmaceuticals market.

Restraints
Factors like complicated and cumbersome regulatory requirements, high-end manufacturing requirements and continuously increasing demand for affordable biopharmaceuticals (which is not possible due to huge development and manufacturing costs) are hindering the market growth.

Opportunities
Currently, the biopharmaceuticals market has great opportunities for both new market entrants and existing players. The patents for several biopharmaceuticals are expiring in the next five years and this creates an opportunity for biosimilars manufacturers. Similarly, no company has yet found a way to effectively reduce the cost of biosimilars and there is a huge market opportunity for any company that can solve this problem.

Challenges
Despite many growth factors driving the biopharmaceuticals market, the market faces severe challenges. These need to be overcome in order to tap the full potential of this market. One such factor is the requirement of cold storage for almost all the biopharmaceuticals. This limits their reach in the developing and third world countries. In addition, the process of developing a biopharmaceutical is also extremely difficult, as it involves living biological systems. This also limits the scalability, as scaling a biological system is different from scaling an equipment-based system.

The current biopharmaceutical products pan across several therapeutic areas and product classes. Based on this, the biopharmaceutical market can be segmented into products and therapeutic area. Based on the product, the biopharmaceuticals market can be segmented into monoclonal antibodies, recombinant growth factors, purified proteins, recombinant proteins, recombinant hormones, synthetic immunomodulators, vaccines and recombinant enzymes, among others. Among these, the monoclonal antibodies happen to be the largest market segment with 37.31% share in the year 2015.

Based on the therapeutic area/application, the biopharmaceuticals market can be segmented into oncology, inflammatory and infectious diseases, autoimmune disorders, metabolic disorders, hormonal disorders, disease prevention, cardiovascular diseases, neurological diseases and other diseases. Among these, oncology happens to be the largest segment with 30.5% share in the year 2015.

Geographically, the biopharmaceuticals market can be segmented into North America (United States, Canada and Mexico), Europe (The United Kingdom, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (Japan, China, Australia, South Korea, India and Rest of Asia-Pacific), Middle East & Africa (Gulf Cooperation Council Countries, South Africa and Rest of Middle East & Africa) and South America (Brazil, Argentina and Rest of South America). Among these, North America was found to be the largest market shareholder with 44.5% of the share in the year 2015.
Due to the huge profit margins and growth prospects, biopharmaceuticals have garnered the attention of several large drug development companies.

Purchase a copy of Biopharmaceuticals Market visit @     http://www.orbisresearch.com/contact/purchase/219756    For more information contact sales@orbisresearch.com       .

Some of the key players in the market are:
Abbott Laboratories
AMgen
AstraZeneca
Biogen Inc.
Bristol-Myers Squibb
Eli Lilly & Company
GlaxoSmithKline
Novo-Nordisk
Pfizer Inc.
Roche Holding AG
Sanofi Aventis

What the Report Offers
Market analysis for the global biopharmaceuticals market, with region-specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.

Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a regional scale.
Extensively researched competitive landscape section with profiles of major companies along with their market share.

Identification and analysis of the macro and micro factors that affect the global biopharmaceuticals market.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.

A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions in which this industry is blooming and the regions that are still untapped.

Some points from TOC:

  1. Introduction
    1.1 Study Deliverables
    1.2 Market definition
    1.3 Sizing Units
    1.4 Base Currency
    1.5 Review and Forecast Periods Years
    1.6 General Study Assumptions
  2. Research methodology
    2.1 Introduction
    2.2 Analysis Methodology
    2.3 Econometric Forecast
    2.4 Research Assumptions
  3. Executive Summary
  4. Key Inferences
  5. Market Overview
    5.1 Overview of Biopharmaceuticals
    5.2 Current Market Scenario
    5.3 Recent Advancements in Biopharmaceuticals
    5.4 PorterFive Forces
    5.4.1 Bargaining Power of Suppliers
    5.4.2 Bargaining Power of Consumers
    5.4.3 Threat of New Entrants
    5.4.4 Threat of Substitute Products and Services
    5.4.5 Competitive Rivalry within the Industry
  6. Drivers, Restraints, Opportunities and Challenges Analysis (DROC)
    6.1 Market Drivers
    6.1.1 Increasing acceptance for Biopharmaceuticals
    6.1.2 Ability of Biopharmaceuticals to treat previously untreatable diseases
    6.1.3 Huge market demand
    6.1.4 High profit margins
    6.2 Market Restraints
    6.2.1 Increasing demand for affordable Biopharmaceuticals
    6.2.2 High-end manufacturing requirements
    6.2.3 Complicated and Cumbersome regulatory requirements
    6.3 Key Challenges
    6.3.1 Extremely difficult development process
    6.3.2 Scalability limited by several out of hand factors
    6.3.3 Requirement of cold chain
    6.4 Current Opportunities in the Market
    6.4.1 Patent expiry paving way for Biosimilars
    6.4.2 Finding ways of cost reduction

 For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:

Hector Costello

Senior Manager – Client Engagements

4144N Central Expressway,

Suite 600, Dallas,

Texas – 75204, U.S.A.

Phone No.: +1 (214) 884-6817; +9164101019

Follow Us on LinkedIn: https://www.linkedin.com/company/orbis-research

Follow us on Twitter: https://twitter.com/orbisresearch

Like us on Facebook: https://www.facebook.com/pages/Orbis-Research/820969017982115

Monday, 12 June 2017

Latest Research: 2017-2022 Pet Pharmaceuticals Market Report

The study of the " Pet Pharmaceuticals Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry.

In our aim to provide our erudite clients with the best research material with absolute in-depth information of the market, our new report on Global Pet Pharmaceuticals Market is confident in meeting their needs and expectations. The 2017 market research report on Global Pet 
Pharmaceuticals Market is an in-depth study and analysis of the market by our industry experts with unparalleled domain knowledge. The report will shed light on many critical points and trends of the industry which are useful for our esteemed clients. The report covers a vast expanse of information including an overview, comprehensive analysis, definitions and classifications, applications, and expert opinions, among others. With the extent of information filled in the report, the presentation and style of the Global Pet Pharmaceuticals Market report is a noteworthy.


The Global Pet Pharmaceuticals Industry report provides key information about the industry, including invaluable facts and figures, expert opinions, and the latest developments across the globe. Not only does the report cover a holistic view of the industry from a global standpoint, but it also covers individual regions and their development. The Global Pet Pharmaceuticals Industry report showcases the latest trends in the global and regional markets on all critical parameters which include technology, supplies, capacity, production, profit, price, and competition. The key players covered in the report provide a detailed analysis of the competition and their developments in the Global Pet Pharmaceuticals Industry. Accurate forecasts and expert opinion from credible sources, and the recent R&D development in the industry is also a mainstay of the Pet Pharmaceuticals Market report.

Purchase a copy of Global Pet Pharmaceuticals Market visit @   http://www.orbisresearch.com/contact/purchase/318590  For more information contact sales@orbisresearch.com     .

The report also focuses on the significance of industry chain analysis and all variables, both upstream and downstream. These include equipment and raw materials, client surveys, marketing channels, and industry trends and proposals. Other significant information covering consumption, key regions and distributors, and raw material suppliers are also a covered in this report.
Finally, the Pet Pharmaceuticals Market report ends with a detailed SWOT analysis of the market, investment feasibility and returns, and development trends and forecasts. As with every report on Orbis Research, the Pet Pharmaceuticals Industry is the holy grail of information which serious knowledge seekers can benefit from. The report which is the result of ultimate dedication of pedigree professionals has a wealth of information which can benefit anyone, irrespective of their commercial or academic interest.


Some points from TOC:
Chapter One: Pet Pharmaceuticals Market Overview
1.1 Product Overview and Scope of Pet Pharmaceuticals
1.2 Pet Pharmaceuticals Segment by Type (Product Category)
1.2.1 Global Pet Pharmaceuticals Production and CAGR (%) Comparison by Type (Product Category) (2012-2022)
1.2.2 Global Pet Pharmaceuticals Production Market Share by Type (Product Category) in 2016
1.2.3 Pill
1.2.4 Injection
1.2.5 Spray
1.2.6 Ointment
1.2.7 Others
1.3 Global Pet Pharmaceuticals Segment by Application
1.3.1 Pet Pharmaceuticals Consumption (Sales) Comparison by Application (2012-2022)
1.3.2 Treatment
1.3.3 Prevention
1.4 Global Pet Pharmaceuticals Market by Region (2012-2022)
1.4.1 Global Pet Pharmaceuticals Market Size (Value) and CAGR (%) Comparison by Region (2012-2022)
1.4.2 North America Status and Prospect (2012-2022)
1.4.3 Europe Status and Prospect (2012-2022)
1.4.4 China Status and Prospect (2012-2022)
1.4.5 Japan Status and Prospect (2012-2022)
1.4.6 Southeast Asia Status and Prospect (2012-2022)
1.4.7 India Status and Prospect (2012-2022)
1.5 Global Market Size (Value) of Pet Pharmaceuticals (2012-2022)
1.5.1 Global Pet Pharmaceuticals Revenue Status and Outlook (2012-2022)
1.5.2 Global Pet Pharmaceuticals Capacity, Production Status and Outlook (2012-2022)

Chapter Two: Global Pet Pharmaceuticals Market Competition by Manufacturers
2.1 Global Pet Pharmaceuticals Capacity, Production and Share by Manufacturers (2012-2017)
2.1.1 Global Pet Pharmaceuticals Capacity and Share by Manufacturers (2012-2017)
2.1.2 Global Pet Pharmaceuticals Production and Share by Manufacturers (2012-2017)
2.2 Global Pet Pharmaceuticals Revenue and Share by Manufacturers (2012-2017)
2.3 Global Pet Pharmaceuticals Average Price by Manufacturers (2012-2017)
2.4 Manufacturers Pet Pharmaceuticals Manufacturing Base Distribution, Sales Area and Product Type
2.5 Pet Pharmaceuticals Market Competitive Situation and Trends
2.5.1 Pet Pharmaceuticals Market Concentration Rate
2.5.2 Pet Pharmaceuticals Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion

For any enquires before buying, connect with us @ enquiry@orbisresearch.com

About Us:
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.

Contact Information:
Hector Costello
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019

Follow us on Twitter: https://twitter.com/orbisresearch